Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
CRISPR screening identifies BET and mTOR inhibitor synergy in cholangiocarcinoma through serine glycine one carbon.
JCI Insight. 2024 Jan 23;9(2):e174220. doi: 10.1172/jci.insight.174220.
JCI Insight. 2024.
PMID: 38060314
Free PMC article.
Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma.
Romano G, Paradiso F, Li P, Shukla P, Barger LN, El Naggar O, Miller JP, Liang RJ, Helms TL, Lazar AJ, Wargo JA, Taraballi F, Costello JC, Kwong LN.
Romano G, et al.
Cancer Immunol Res. 2023 May 3;11(5):558-569. doi: 10.1158/2326-6066.CIR-22-0224.
Cancer Immunol Res. 2023.
PMID: 36820825
Free PMC article.
Item in Clipboard
The immunogenomic landscape of resected intrahepatic cholangiocarcinoma.
Carapeto F, Bozorgui B, Shroff RT, Chagani S, Solis Soto L, Foo WC, Wistuba I, Meric-Bernstam F, Shalaby A, Javle M, Korkut A, Kwong LN.
Carapeto F, et al.
Hepatology. 2022 Feb;75(2):297-308. doi: 10.1002/hep.32150. Epub 2021 Dec 6.
Hepatology. 2022.
PMID: 34510503
Free PMC article.
Item in Clipboard
Cite
Cite